Functional and evolutionary insight from the crystal structure of rubella virus protein E1

Nature

Volumn 493, Issue 7433, 2013, Pages 552-556

  Dubois, Rebecca M ^a   Vaney, Marie Christine ^a   Tortorici, M Alejandra ^a   Kurdi, Rana Al ^a   Barba Spaeth, Giovanna ^a   Krey, Thomas ^a   Rey, Félix A ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; HYBRID PROTEIN; MEASLES MUMPS RUBELLA VACCINE; MUCIN; NEUTRALIZING ANTIBODY; PHOSPHATIDYLSERINE; T LYMPHOCYTE ANTIBODY;

ANTIBODY; APOPTOSIS; ARTHROPOD; CRYSTAL STRUCTURE; DEVELOPING WORLD; DISEASE VECTOR; EVOLUTIONARY BIOLOGY; IMMUNOASSAY; MEASLES; MEMBRANE; MOSQUITO; PROTEIN; THREE-DIMENSIONAL MODELING; VERTEBRATE; VIRUS;

ALPHA VIRUS; APOPTOSIS; ARTHROPOD; ARTICLE; CELL MEMBRANE; FLAVIVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RUBELLA VIRUS;

ANIMALS; BINDING SITES; BIOLOGICAL EVOLUTION; CELL LINE; CRYSTALLOGRAPHY, X-RAY; DROSOPHILA MELANOGASTER; EVOLUTION, MOLECULAR; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MEMBRANE FUSION; METALS; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; RUBELLA SYNDROME, CONGENITAL; RUBELLA VIRUS; VIRAL ENVELOPE PROTEINS;

ARBOVIRUS; ARTHROPODA; RUBELLA; RUBELLA VIRUS; RUBIVIRUS; VERTEBRATA;

EID: 84872973964     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11741     Document Type: Article

References (41)

1. Hobman, T. C.&Chantler, J. K. in Fields Virology Vol. 1 (ed. D. M. Knipe) 1069-1100 (Lippincott Williams & Wilkins, 2007).
2. Katow, S. & Sugiura, A. Antibody response to individual rubella virus proteins in congenital and other rubella virus infections. J. Clin.Microbiol. 21, 449-451 (1985).
3. Cong, H., Jiang, Y. & Tien, P. Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus. J. Virol. 85, 11038-11047 (2011).
4. Katow, S. & Sugiura, A. Low pH-induced conformational change of rubella virus envelope proteins. J. Gen. Virol. 69, 2797-2807 (1988).
5. Kee, S. H. et al. Effects of endocytosis inhibitory drugs on rubella virus entry into VeroE6 cells. Microbiol. Immunol. 48, 823-829 (2004).
6. Petruzziello, R. et al. Pathway of rubella virus infectious entry into Vero cells. J. Gen. Virol. 77, 303-308 (1996).
7. Gibbons, D. L. et al. Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell 114, 573-583 (2003).
8. Stiasny, K., Allison, S. L., Schalich, J. & Heinz, F. X. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J. Virol. 76, 3784-3790 (2002).
9. Stiasny, K., Bressanelli, S., Lepault, J., Rey, F. A. & Heinz, F. X. Characterization of a membrane-associated trimeric low-pH-induced form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J. Virol. 78, 3178-3183 (2004).
10. Bennett, M. J., Schlunegger, M. P. & Eisenberg, D. 3D domain swapping: a mechanism for oligomer assembly. Protein Sci. 4, 2455-2468 (1995).
11. Holm, L. & Rosenstrom, P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38, W545-W549 (2010).
12. Qiu, Z., Yao, J., Cao, H. & Gillam, S. Mutations in the E1 hydrophobic domain of rubella virus impair virus infectivity but not virus assembly. J. Virol.74, 6637-6642 (2000).
13. Santiago, C. et al. Structures of T cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity 26, 299-310 (2007).
14. Goldstein, D. A. in Clinical Methods: The History, Physical, and Laboratory Examinations Ch 143 (eds H. K. Walker, W. D. Hall, & J. W. Hurst) 677-679 (1990).
15. Mastromarino, P., Cioe, L., Rieti, S.& Orsi, N. Role of membrane phospholipids and glycolipids in the Vero cell surface receptor for rubella virus. Med. Microbiol. Immunol. 179, 105-114 (1990).
16. Kobayashi, T. et al. Separation and characterization of late endosomalmembrane domains. J. Biol. Chem. 277, 32157-32164 (2002).
17. Wolinsky, J. S. et al. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. J. Virol. 67, 961-968 (1993).
18. Mitchell, L. A. et al.Characterization of rubella virus-specific antibody responses by using a newsynthetic peptide-based enzyme-linkedimmunosorbent assay. J. Clin. Microbiol. 30, 1841-1847 (1992).
19. Battisti, A. J. et al. Cryo-electron tomography of rubella virus. J. Virol. 86, 11078-11085 (2012).
20. Krey, T. et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 6, e1000762 (2010).
21. Roussel, A., Lescar, J., Vaney, M. C., Wengler, G. & Rey, F. A. Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure 14, 75-86 (2006).
22. Voss, J. E. et al. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468, 709-712 (2010).
23. Bressanelli, S. et al. Structure of a flavivirus envelope glycoprotein in its low-pHinduced membrane fusion conformation. EMBO J. 23, 728-738 (2004).
24. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2Å resolution. Nature 375, 291-298 (1995).
25. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319 (2004).
26. Nayak, V. et al. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 83, 4338-4344 (2009).
27. Roche, S., Bressanelli, S., Rey, F. A.&Gaudin, Y. Crystal structure of the low-pHform of the vesicular stomatitis virus glycoprotein G. Science 313, 187-191 (2006).
28. Heldwein, E. E. et al. Crystal structure of glycoproteinBfromherpes simplex virus1. Science 313, 217-220 (2006).
29. Backovic, M., Longnecker, R. & Jardetzky, T. S. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl Acad. Sci. USA 106, 2880-2885 (2009).
30. Kadlec, J., Loureiro, S., Abrescia, N. G., Stuart, D. I. & Jones, I. M. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nature Struct. Mol. Biol. 15, 1024-1030 (2008).
31. Kabsch, W. XDS. Acta Crystallogr. D 66, 125-132 (2010).
32. Schneider, T. R. & Sheldrick, G. M. Substructure solution with SHELXD. Acta Crystallogr. D 58, 1772-1779 (2002).
33. Vonrhein, C., Blanc, E., Roversi, P.&Bricogne, G. Automated structure solution with autoSHARP. Methods Mol. Biol. 364, 215-230 (2007).
34. Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M. & Paciorek, W. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. Acta Crystallogr. D 59, 2023-2030 (2003).
35. Abrahams, J. P. & Leslie, A. G. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D 52, 30-42 (1996).
36. Cowtan, K. dm: an automated procedure for phase improvement by density modification. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 31, 34-38 (1994).
37. Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nature Protocols 3, 1171-1179 (2008).
38. Bricogne, G. et al. BUSTER, version 2.8.0 (Global Phasing, 2009).
39. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
40. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
41. Castile, J. D. & Taylor, K. M. Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion. Int. J. Pharm. 188, 87-95 (1999).